📰 Stephens Yoder News
Stephens Yoder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stephens Yoder. Real-time updates on events, politics, business and more.
August 17, 2023
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals ...
May 10, 2023
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results ...
May 4, 2023
Pieris Pharmaceuticals Announces Successful Completion of Safety Review ...
March 29, 2023
COMPANY TO HOST AN INVESTOR CONFERENCE CALL TODAY, WEDNESDAY, MARCH 29, 2023, AT 8:00 AM EDTContinued advancement of pipeline, including two clinical-stage inhaled respiratory programs and additional therapeutic
March 29, 2023
Pieris Pharmaceuticals Reports Full-Year 2022 Financial Results and ...
January 10, 2023
BOSTON, MA / ACCESSWIRE / January 10, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology
November 2, 2022
COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2, 2022 AT 8:00 AM EDTElarekibep (PRS-060/AZD1402) phase 2a study for asthma enrollment continuesFirst subject dosed in PRS-220 phase
August 4, 2022
COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON THURSDAY, AUGUST 4, 2022 AT 8:00 AM EDTAdjustments to PRS-060/AZD1402 phase 2 study design boost enrollment rate and facilitate a topline readout by 3Q23Cinrebafusp
May 11, 2022
Company To Host an Investor Conference Call On Wednesday, May 11, 2022 At 8:00 Am EDTBOSTON, MA / ACCESSWIRE / May 11, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology
May 11, 2022
Pieris Pharmaceuticals, Inc (NASDAQ:NASDAQ:PIRS) Q1 2022 Earnings Conference Call May 11, 2022, 8:00 AM ET Company Participants Stephen S.